Pages that link to "Q48839615"

The following pages link to Evaluation of prognostic factors in chemotherapy of recurrent brain tumors (Q48839615):

Displaying 13 items.

• Combination radiofrequency hyperthermia and chemotherapy (BCNU) for brain malignancy. Animal experience and two case reports (Q33277919) (← links)
• Prognostic factors for survival in adult patients with recurrent glioma enrolled onto the new approaches to brain tumor therapy CNS consortium phase I and II clinical trials (Q33288097) (← links)
• Phase II study of Cloretazine for the treatment of adults with recurrent glioblastoma multiforme (Q33373293) (← links)
• Comprehensive phase II evaluation of aziridinylbenzoquinone (AZQ, diaziquone) in recurrent human primary brain tumors (Q33451872) (← links)
• Improving vaccine efficacy against malignant glioma (Q38953024) (← links)
• The basis for current treatment recommendations for malignant gliomas (Q40560864) (← links)
• A critique of the role of the blood-brain barrier in the chemotherapy of human brain tumors (Q40560871) (← links)
• Drug resistance in brain tumors (Q40560888) (← links)
• Multimodality management of recurrent adult malignant gliomas: results of a phase II multiagent chemotherapy study and analysis of cytoreductive surgery (Q41021915) (← links)
• Chemotherapy of astrocytomas: an overview (Q41721328) (← links)
• Functionality of hypoxia-induced BAX expression in a human glioblastoma xenograft model (Q45881209) (← links)
• Pilot study of 6 weeks of chemoradiotherapy with 5 FU and hydroxyurea in malignant gliomas (Q48368990) (← links)
• Fluctuation of serum phenytoin concentrations during autologous bone marrow transplant for primary central nervous system tumors (Q48602082) (← links)